loadpatents
Patent applications and USPTO patent grants for KARASEK; Charlie.The latest application filed is for "anti-pacap antibodies and uses thereof".
Patent | Date |
---|---|
Anti-pacap Antibodies And Uses Thereof App 20220289836 - LOOMIS; Maria-Cristina ;   et al. | 2022-09-15 |
Anti-ACTH antibodies and use thereof Grant 11,427,631 - Feldhaus , et al. August 30, 2 | 2022-08-30 |
Anti-PACAP antibodies and uses thereof Grant 11,352,409 - Loomis , et al. June 7, 2 | 2022-06-07 |
Humanized Anti-acth Antibodies And Use Thereof App 20220073606 - Feldhaus; Andrew Lawrence ;   et al. | 2022-03-10 |
Anti-PACAP antibodies Grant 11,254,741 - Loomis , et al. February 22, 2 | 2022-02-22 |
Methods Of Determining Whether Anti-pacap Antibodies Inhibit Pacap-associated Photophobia Or Light Aversion App 20210380676 - KUBURAS; Adisa ;   et al. | 2021-12-09 |
Use Of Anti-pacap Antibodies And Antigen Binding Fragments Thereof For Treatment, Prevention, Or Inhibition Of Photophobia App 20210324068 - KUBURAS; Adisa ;   et al. | 2021-10-21 |
Humanized anti-ACTH antibodies and use thereof Grant 11,117,960 - Feldhaus , et al. September 14, 2 | 2021-09-14 |
Anti-pacap Antibodies And Uses Thereof App 20210277106 - LOOMIS; Maria-Cristina ;   et al. | 2021-09-09 |
Anti-pacap Antibodies App 20210221884 - LOOMIS; Maria-Cristina ;   et al. | 2021-07-22 |
Humanized Anti-pacap Antibodies And Uses Thereof App 20210179688 - LOOMIS; Maria-Cristina ;   et al. | 2021-06-17 |
Anti-PACAP antibodies Grant 10,981,985 - Loomis , et al. April 20, 2 | 2021-04-20 |
Methods of determining whether anti-PACAP antibodies inhibit PACAP-associated photophobia or light aversion Grant 10,981,984 - Kuburas , et al. April 20, 2 | 2021-04-20 |
Humanized anti-PACAP antibodies Grant 10,975,135 - Loomis , et al. April 13, 2 | 2021-04-13 |
Humanized anti-PACAP antibodies Grant 10,968,268 - Loomis , et al. April 6, 2 | 2021-04-06 |
Humanized anti-PACAP antibodies Grant 10,954,285 - Loomis , et al. March 23, 2 | 2021-03-23 |
Humanized anti-PACAP antibodies and uses thereof Grant 10,913,783 - Loomis , et al. February 9, 2 | 2021-02-09 |
Anti-PACAP antibodies Grant 10,899,834 - Loomis , et al. January 26, 2 | 2021-01-26 |
Use of anti-pacap antibodies and antigen binding fragments thereof for treatment, prevention, or inhibition of photophobia Grant 10,844,116 - Kuburas , et al. November 24, 2 | 2020-11-24 |
Anti-acth Antibodies And Use Thereof App 20200317772 - FELDHAUS; Andrew Lawrence ;   et al. | 2020-10-08 |
Humanized Anti-pacap Antibodies And Uses Thereof App 20200181229 - Loomis; Maria-Cristina ;   et al. | 2020-06-11 |
Humanized Anti-pacap Antibodies And Uses Thereof App 20200181230 - LOOMIS; Maria-Cristina ;   et al. | 2020-06-11 |
Humanized Anti-acth Antibodies And Use Thereof App 20200172611 - Feldhaus; Andrew Lawrence ;   et al. | 2020-06-04 |
Anti-pacap Antibodies And Uses Thereof App 20200172612 - LOOMIS; Maria-Cristina ;   et al. | 2020-06-04 |
Humanized Anti-pacap Antibodies And Uses Thereof App 20200165316 - LOOMIS; Maria-Cristina ;   et al. | 2020-05-28 |
Anti-pacap Antibodies App 20200079847 - LOOMIS; Maria-Cristina ;   et al. | 2020-03-12 |
Anti-ACTH antibodies and use thereof Grant 10,550,180 - Feldhaus , et al. Fe | 2020-02-04 |
Humanized anti-ACTH antibodies and use thereof Grant 10,544,214 - Feldhaus , et al. Ja | 2020-01-28 |
Use Of Anti-pacap Antibodies And Antigen Binding Fragments Thereof For Treatment, Prevention, Or Inhibition Of Photophobia App 20190270807 - KUBURAS; Adisa ;   et al. | 2019-09-05 |
Anti-pacap Antibodies And Uses Thereof App 20190233498 - Loomis; Maria-Cristina ;   et al. | 2019-08-01 |
Humanized Anti-acth Antibodies And Use Thereof App 20190085073 - Feldhaus; Andrew Lawrence ;   et al. | 2019-03-21 |
Anti-PACAP antibodies and uses thereof Grant 10,202,435 - Loomis , et al. Feb | 2019-02-12 |
Methods of determining whether anti-PACAP (adenylate cyclase-activating peptide) antibodies or anti-PACAP antigen binding fragments inhibit PACAP-associated photophobia or light aversion Grant 10179813 - | 2019-01-15 |
Humanized anti-ACTH antibodies and use thereof Grant 10,047,157 - Feldhaus , et al. August 14, 2 | 2018-08-14 |
Anti-acth Antibodies And Use Thereof App 20170334987 - FELDHAUS; Andrew Lawrence ;   et al. | 2017-11-23 |
Anti-pacap Antibodies And Uses Thereof App 20170298127 - LOOMIS; Maria-Cristina ;   et al. | 2017-10-19 |
Humanized Anti-pacap Antibodies And Uses Thereof App 20170298115 - LOOMIS; Maria-Cristina ;   et al. | 2017-10-19 |
Anti-ACTH antibodies and use thereof Grant 9,688,754 - Feldhaus , et al. June 27, 2 | 2017-06-27 |
Use Of Anti-pacap Antibodies And Antigen Binding Fragments Thereof For Treatment, Prevention, Or Inhibition Of Photophobia App 20160376363 - KUBURAS; Adisa ;   et al. | 2016-12-29 |
Use Of Anti-pacap Antibodies And Antigen Binding Fragments Thereof For Treatment, Prevention, Or Inhibition Of Photophobia App 20160361441 - KUBURAS; Adisa ;   et al. | 2016-12-15 |
Anti-pacap Antibodies And Uses Thereof App 20160362488 - LOOMIS; Maria-Cristina ;   et al. | 2016-12-15 |
Anti-pacap Antibodies And Uses Thereof App 20160304604 - LOOMIS; Maria-Cristina ;   et al. | 2016-10-20 |
Humanized Anti-acth Antibodies And Use Thereof App 20160215049 - Feldhaus; Andrew Lawrence ;   et al. | 2016-07-28 |
Anti-acth Antibodies And Use Thereof App 20150259414 - FELDHAUS; Andrew Lawrence ;   et al. | 2015-09-17 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.